Comparison of Subsequent Inframalleolar Bypass Surgery and Repeat Endovascular Therapy for Infrapopliteal Restenosis in Patients With Chronic Limb-Threatening Ischemia Undergoing Primary Endovascular Therapy

Abstract

Purpose:

Although endovascular therapy (EVT) is considered a vital strategy for treating infrapopliteal lesions in chronic limb-threatening ischemia (CLTI), the recurrence rate after EVT exceeds that after bypass surgery (BSX). The optimal approach for managing infrapopliteal lesion recurrence in patients with CLTI and unhealed ulcers remains uncertain. This study aimed to evaluate the clinical outcomes of repeat EVT and subsequent inframalleolar BSX for CLTI with infrapopliteal lesion recurrence.

Materials and Methods:

We conducted a retrospective analysis of 140 patients with CLTI (mean age, 70±10 years; male, 71.4%; diabetes mellitus, 73.6%; dialysis, 74.3%; Rutherford 5, 79.3%; and Rutherford 6, 20.7%) who had an unhealed wound due to the recurrence of infrapopliteal lesions between January 2015 and May 2020. We compared the clinical outcomes of 40 patients who underwent the subsequent inframalleolar BSX with those of 100 patients who underwent repeat EVT. The outcome measures were amputation-free survival (AFS) and wound healing rate. Propensity score matching analysis was conducted to minimize differences in baseline characteristics.

Results:

Propensity score matching extracted 38 pairs (38 patients in the subsequent BSX group and 83 patients in the repeat EVT group). AFS was not significantly different between the repeat EVT and subsequent BSX groups (81.9% vs 82.6% at 1 year, p=0.97). Neither was cumulative wound healing (42.8% vs 43.3% at 1 year, p=0.55). No baseline characteristics had any significant interaction effect on the association between repeat EVT, subsequent BSX, and failure of AFS.

Conclusion:

This study using propensity score matching revealed that the clinical outcomes following repeat EVT were comparable with those following subsequent inframalleolar BSX, indicating that repeat EVT may be a viable treatment option for CLTI with infrapopliteal lesion recurrence.

Clinical Impact

Although endovascular therapy (EVT) has expanded the treatment options for chronic limb-threatening ischemia (CLTI), the recurrence rate after EVT is higher than that after bypass surgery (BSX). This retrospective study compared the clinical outcomes of repeat EVT with those of subsequent BSX for CLTI with infrapopliteal lesion recurrence. After propensity score matching, amputation-free survival (AFS) was not significantly different between the repeat EVT and subsequent BSX groups (81.9% vs 82.6% at 1 year, p=0.97). Neither was cumulative wound healing (42.8% vs 43.3% at 1 year, p=0.55). There was no difference between the 2 revascularization strategies when treating infrapopliteal restenosis lesions.

Keywords

chronic limb ischemia endovascular treatment/therapy inframalleolar bypass reintervention wound healing

Get full access to this article

View all access options for this article.

References

Norgren

Hiatt

Dormandy

, et al Inter-society consensus for the management of peripheral arterial disease (TASC II). J Vasc Surg. 2007;45 (suppl S):S5–S67.

Conte

Bradbury

Kolh

, et al Global vascular guidelines on the management of chronic limb-threatening ischemia. J Vasc Surg. 2019;69(6S):3S–125S.e40.

Iida

Takahara

Soga

, et al Three-year outcomes of surgical versus endovascular revascularization for critical limb ischemia: the SPINACH study (surgical reconstruction versus peripheral intervention in patients with critical limb ischemia). Circ Cardiovasc Interv. 2017;10(12):e005531.

Utsunomiya

Iida

Yamauchi

, et al Influence of repeat intervention on the risk of major amputation after infrapopliteal angioplasty for critical limb ischemia. J Endovasc Ther. 2016;23(5):710–716.

Iida

Nanto

Uematsu

, et al Importance of the angiosome concept for endovascular therapy in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2010;75(6):830–836.

Schultz

Sibbald

Falanga

, et al Wound bed preparation: a systematic approach to wound management. Wound Repair Regen. 2003;11(suppl 1):S1–S28.

von Allmen

Weiss

Tevaearai

, et al Completeness of follow-up determines validity of study findings: results of a prospective repeated measures cohort study. PLoS ONE. 2015;10(10):e0140817.

Mills

Sr Conte

Armstrong

, et al The society for vascular surgery lower extremity threatened limb classification system: risk stratification based on wound, ischemia, and foot infection (WIfI). J Vasc Surg. 2014;59(1):220–234.

Ming

Rosenbaum

PR.

Substantial gains in bias reduction from matching with a variable number of controls. Biometrics. 2000;56(1):118–124.

10.

Benedetto

Spinelli

Pipitò

, et al Inframalleolar bypass for chronic limb-threatening ischemia. Vasc Med. 2021;26(2):187–194.

11.

Iida

Soga

Yamauchi

, et al Clinical efficacy of endovascular therapy for patients with critical limb ischemia attributable to pure isolated infrapopliteal lesions. J Vasc Surg. 2013;57(4):974–981.

12.

Romiti

Albers

Brochado-Neto

, et al Meta-analysis of infrapopliteal angioplasty for chronic critical limb ischemia. J Vasc Surg. 2008;47(5):975–981.

13.

Adam

Beard

Cleveland

, et al Bypass versus angioplasty in severe ischaemia of the leg (BASIL): multicentre, randomised controlled trial. Lancet. 2005;366(9501):1925–1934.

14.

Farber

Menard

Conte

, et al Surgery or endovascular therapy for chronic limb-threatening ischemia. N Engl J Med. 2022;387(25):2305–2316.

15.

Bradbury

Moakes

Popplewell

, et al A vein bypass first versus a best endovascular treatment first revascularisation strategy for patients with chronic limb threatening ischaemia who required an infra-popliteal, with or without an additional more proximal infra-inguinal revascularisation procedure to restore limb perfusion (BASIL-2): an open-label, randomised, multicentre, phase 3 trial. Lancet. 2023;401(10390):1798–1809.

16.

Iida

Nakamura

Yamauchi

, et al 3-year outcomes of the OLIVE registry, a prospective multicenter study of patients with critical limb ischemia: a prospective, multi-center, three-year follow-up study on endovascular treatment for infra-inguinal vessel in patients with critical limb ischemia. JACC Cardiovasc Interv. 2015;8(11):1493–1502.

17.

Singh

Armstrong

Yeo

, et al Endovascular recanalization of infrapopliteal occlusions in patients with critical limb ischemia. J Vasc Surg. 2014;59(5):1300–1307.

18.

Bradbury

Adam

Bell

, et al Bypass versus angioplasty in severe ischaemia of the leg (BASIL) trial: analysis of amputation free and overall survival by treatment received. J Vasc Surg. 2010;51(suppl 5):18S–31S.

19.

Tsuji

Shiraki

Iida

, et al Impact of infrapopliteal endovascular treatment on the outcome of subsequent ipsilateral distal bypass for critical limb ischemia. J Cardiovasc Surg (Torino). 2017;58(6):828–834.

20.

Morisaki

Yamaoka

Iwasa

, et al Bypass surgery after endovascular therapy for infrapopliteal lesion is not a poor outcome compared with initial bypass surgery by vascular surgeons. Ann Vasc Surg. 2017;45:35–41.

21.

Kobayashi

Hirano

Yamawaki

, et al Characteristics and clinical outcomes of repeat endovascular therapy after infrapopliteal balloon angioplasty in patients with critical limb ischemia. Catheter Cardiovasc Interv. 2018;91(3):505–514.

22.

Baumann

Bloesch

Engelberger

, et al Clinically-driven need for secondary interventions after endovascular revascularization of tibial arteries in patients with critical limb ischemia. J Endovasc Ther. 2013;20(5):707–713.

23.

Shannon

Mehaffey

Cullen

, et al A comparison of outcomes after lower extremity bypass and repeat endovascular intervention following failed previous endovascular intervention for critical limb ischemia. Angiology. 2019;70(6):501–505.